NCT03986502

Brief Summary

This trial studies how well a financial navigation intervention works in improving financial and clinical outcomes in patients with newly diagnosed gastric or gastroesophageal junction adenocarcinoma. Financial toxicity is a term used to summarize cancer-related financial hardship, including both the material (e.g. debt) and psychological (e.g. anxiety about costs) aspects. Cancer patients who experience financial toxicity are at greater risk for treatment non-adherence, poorer quality of life, and worse survival. Caregivers also share in this experience of financial toxicity and often spend money on food, medications, and other patient needs in addition to taking time off from work to provide logistical, emotional, and medical support. Financial navigation interventions that address the shared household financial concerns of patients and their caregivers may not only improve the patient outcomes but also improve caregiver burden, quality of life, and ability to perform caregiver roles more effectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 14, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 22, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

October 14, 2022

Status Verified

October 1, 2022

Enrollment Period

1.7 years

First QC Date

June 10, 2019

Last Update Submit

October 12, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Number of Participants that have experienced Household financial hardship

    Financial Hardship is defined as self-report of accrual of debt, taking out loans for cancer treatment or decline in household income \<=20%

    Up to 6 months

  • Patient quality of life: FACT-G

    Composite score from the FACT-G. A 6-point score change is considered clinically meaningful in US cancer populations.

    Baseline up to 6 months

  • Subjective financial distress

    Assessed using Comprehensive Score for Financial Toxicity-Patient Reported Outcome Measure (COST-FACIT). Mean scores (and standard deviations) at 3 and 6 months will be compared between intervention and control patients and caregivers using two sample t tests. Additionally, will explore the extent to which subjective financial distress correlates with financial hardship by comparing mean scores in those who experience financial hardship in each study arm versus those who do not.

    Baseline up to 6 months

  • Qualitative assessment of usual care and intervention

    Usual care arm dyads will be surveyed about availability (or lack), access to, and use of financial assistance via the clinic and community. Intervention arm dyads will be surveyed about availability and use of financial assistance from the clinic, community, and navigation partners. Will evaluate Consumer Education and Training Services (CENTS)'s and Patient Advocate Foundation (PAF)'s documentation and characterize the interventions made on behalf of dyads in subgroups categorized by age, gender, income, and financial fragility. We will review all unresolved issues reported by CENTS and PAF and describe the frequency and type by subgroup. We will describe dyads' use of clinic and community-based financial assistance resources in both study arms across subgroups, noting barriers to access if present.

    Up to 6 months

  • Caregiver quality of life

    City of Hope Quality of Life Family version, a well-validated tool with 37 items and 4 subscales (scored 0-10 per item). A change in score of 2 points per item is considered clinically meaningful.

    Baseline up to 6 months

  • Caregiver burden

    Assessed via the social well-being subscale of the City of Hope Quality of Life questionnaire.

    Baseline up to 6 months

Study Arms (2)

Arm I (financial navigation program)

EXPERIMENTAL

Patients and caregivers watch a web-based financial literacy video and receive information about financial counseling, direct medical cost and healthcare coverage assistance, and indirect and non-medical cost assistance.

Other: Media InterventionOther: Informational InterventionOther: Questionnaire AdministrationOther: Quality-of-Life Assessment

Arm II (usual care)

ACTIVE COMPARATOR

Patients and caregivers participate in usual clinic procedures and utilize any available clinic or community-based financial resources. Patients and caregivers will also be provided the financial navigation videos and worksheets from the intervention.

Other: Best PracticeOther: Questionnaire AdministrationOther: Quality-of-Life Assessment

Interventions

Watch web-based financial literacy video

Arm I (financial navigation program)

Receive information on financial counseling and medical cost assistance

Arm I (financial navigation program)

Utilize usual clinic procedures and clinic or community-based financial resources

Also known as: standard of care, standard therapy
Arm II (usual care)

Ancillary studies

Arm I (financial navigation program)Arm II (usual care)

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (financial navigation program)Arm II (usual care)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PATIENT: English-speaking
  • PATIENT: Diagnosis of gastric and/or gastroesophageal junction (GEJ) adenocarcinoma within 6 months of consent (any stage)
  • PATIENT: Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
  • PATIENT: Receiving (or will receive) chemotherapy, radiation, or other systemic therapy (including targeted drug or immune checkpoint inhibitor)
  • CAREGIVER: English-speaking

You may not qualify if:

  • PATIENT: Enrolled in hospice care at the time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States

Location

Related Publications (1)

  • Bell-Brown A, Hopkins T, Watabayashi K, Overstreet K, Leahy A, Bradshaw E, Gallagher K, Obenchain J, Padron A, Scott B, Flores B, Shankaran V. A proactive financial navigation intervention in patients with newly diagnosed gastric and gastroesophageal junction adenocarcinoma. Support Care Cancer. 2024 Feb 24;32(3):189. doi: 10.1007/s00520-024-08399-1.

MeSH Terms

Interventions

Practice Guidelines as TopicStandard of Care

Intervention Hierarchy (Ancestors)

Guidelines as TopicQuality Assurance, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationQuality Indicators, Health Care

Study Officials

  • Veena Shankaran

    Fred Hutch/University of Washington Cancer Consortium

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2019

First Posted

June 14, 2019

Study Start

January 22, 2021

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

October 14, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations